FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: An FDA approval for Moderna's mRNA flu vaccine could offer Alaskans a new option for influenza prevention, potentially impacting public health strategies across the state, especially given the remote nature of many communities and the importance of accessible preventative care.

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.